Evidence map›Paper›PMID 27315125›Full record

ArticleCerebellum (London, England)2016

Carriage of One or Two FMR1 Premutation Alleles Seems to Have No Effect on Illness Severity in a FXTAS Female with an Autozygous FMR1 Premutation Allele.

Laia Rodriguez-Revenga, Javier Pagonabarraga, Beatriz Gómez-Anson, Olga López-Mourelo, Silvia Izquierdo, Maria Isabel Alvarez-Mora, Esther Granell, Irene Madrigal, Montserrat Milà

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Cerebellum (London, England), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact, top 96% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Premutation Females with preFXTAS.International journal of molecular sciences · 2025
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 1 country.

Laia Rodriguez-RevengaBiochemistry and Molecular Genetics Service, Hospital Clínic, C/Villarroel, 170, 08036, Barcelona, Spain.
Javier PagonabarragaNeurology Service, Hospital Sant Pau, Barcelona, Spain.
Beatriz Gómez-AnsonNeuroradiology Unit, Radiology Department, Hospital Sant Pau, Barcelona, Spain.
Olga López-MoureloPIC, IFAE, Universitat Autònoma Barcelona, Barcelona, Spain.
Silvia IzquierdoSección de Genética Clínica y Reproducción Asistida, Servicio de Bioquímica Clínica, Hospital Universitario Miguel Servet, Zaragoza, Spain.
Maria Isabel Alvarez-MoraBiochemistry and Molecular Genetics Service, Hospital Clínic, C/Villarroel, 170, 08036, Barcelona, Spain.
Esther GranellNeuroradiology Unit, Radiology Department, Hospital Sant Pau, Barcelona, Spain.
Irene MadrigalBiochemistry and Molecular Genetics Service, Hospital Clínic, C/Villarroel, 170, 08036, Barcelona, Spain.
Montserrat MilàBiochemistry and Molecular Genetics Service, Hospital Clínic, C/Villarroel, 170, 08036, Barcelona, Spain. mmila@clinic.ub.es.
Centre for Biomedical Network Research on Rare Diseases · ESInstitute for High Energy Physics · ESCentro de Investigación en Red en Enfermedades Cardiovasculares · ESHospital de Sant Pau · ESHospital Universitario Miguel Servet · ESUniversitat Autònoma de Barcelona · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fragile X-associated tremor/ataxia syndrome (FXTAS) is a late-onset neurodegenerative disorder that occurs in FMR1 premutation carriers. The prevalence of FMR1 premutation carriers in the general population is relatively high, and although rare, a premutation in both X chromosomes may occur in females inheriting a premutation allele from each of both parent carriers. Here, we report the first female with an autozygous (homozygous by descendent) FMR1 premutation allele, who fulfills neurological and radiological FXTAS findings/criteria. Molecular characterization included CGG repeat length, AGG interruption pattern, FMR1 messenger RNA (mRNA), fragile X mental retardation protein (FMRP) level quantification, and single-nucleotide polymorphism (SNP) microarray. Neuroradiological assessment of 3-T magnetic resonance imaging and neurological and cognitive/neuropsychological evaluations were performed. Neurological and neuroradiological examination of the female with the same FMR1 allele in the premutation range (77 CGGs) demonstrated FXTAS features. Further familial evaluation showed a similar neuropsychiatric profile, with impairments in cognitive flexibility and visuospatial function, mainly. A unique family with an autozygous FMR1 premutation female is presented. Neurological/cognitive and neuroradiological examinations revealed FXTAS-specific findings in the female with the autozygous FMR1 premutation allele. The consistent molecular and cognitive/psychiatric phenotype in family members suggests that carrying one or two FMR1 premutation alleles has no effect on illness severity.

Indexed as

Gene DosageAdultAgedAged, 80 and overAllelesAtaxiaBrainFamilyFemaleFragile X Messenger Ribonucleoprotein 1Fragile X SyndromeHeterozygoteHumansMaleMiddle AgedSeverity of Illness IndexFMR1 protein, humanFragile X Messenger Ribonucleoprotein 1FMR1 geneFMR1 premutation carrierFXTAS

Identifiers

PMID27315125
OpenAlexW2433255621

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.